Table 3.
Overall population (n = 1021) | Acute HFrEF (n = 199) | Acute HFpEF (n = 97) | Non‐AHF (n = 725) | |||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P‐value | HR (95% CI) | P‐value | HR (95% CI) | P‐value | HR (95% CI) | P‐value | |
B‐lines > 30 | 2.45 (1.49–4.02) | <0.0001 | 1.63 (0.86–3.09) | 0.12 | 5.54 (1.35–22.73) | 0.017 | 3.044 (1.12–8.26) | 0.029 |
TR velocity > 2.8 m/s | 1.89 (1.15–3.02) | 0.011 | 1.05 (0.53–2.05) | 0.89 | 2.41 (0.30–19.45) | 0.41 | 2.05 (0.94–4.44) | 0.070 |
LVEF < 50% | 2.30 (1.38–3.84) | 0.001 | — | — | — | — | 0.37 (0.17–0.82) | 0.014 |
TAPSE < 17 mm | 1.61 (1.01–2.56) | 0.044 | 2.14 (1.12–4.07) | 0.021 | 2.79 (0.68–11.46) | 0.16 | 0.96 (0.40–2.26) | 0.918 |
AHF, acute heart failure; CI, confidence interval; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.
Note: Numbers marked in bold indicate numbers that are significant.